CLINICAL TRIALS

Phase III clinical trials for TH07

The Triple Hair team is recruiting for a Phase III clinical trial in Canada for TH07, our patented topical treatment for hair loss. The study will evaluate how well TH07 improves hair density compared with a gold-standard medication and a placebo.

 

We are currently looking for men experiencing hair loss to participate in this clinical study.

 

Do you meet the criteria below?  Apply today and help bring an innovative product to market that will change the lives of millions of people.

THE PHASE III
CLINICAL TRIALS
WILL EVALUATE A
6-MONTH TREATMENT

Eligibility criteria

MALE
BETWEEN 18 AND 49 YEARS OLD
CANADIAN
YOU DIDN'T USE ANY INVESTIGATIONAL OR MARKETED DRUG (I.E. MINOXIDIL, ...) IN THE LAST 90 DAYS OR HAD A SURGICAL TREATMENT FOR HAIR LOSS.
WE'RE LOOKING FOR PATIENTS WHOSE DEGREE OF BALDNESS RANKS BETWEEN 3 VERTEX AND 5 ON THE NORWOOD SCALE.
NORWOOD SCALE

Apply

By joining our clinical trial, participants gain access to a closely supervised investigational treatment and play a direct role in advancing hair loss science. Our dedicated team upholds the highest clinical standards and is committed to guiding you through every step of the process. All eligible candidates will be personally contacted before the trial begins to walk through the details and address any questions.

 

Click NOW on the nearest clinic listed below and complete a short eligibility questionnaire.

 

Dr. Braun Site (Vancouver)

 

Dr. Taher Site (Edmonton)

 

Dr. Vance Elliott Site (Edmonton)

 

Dr. Martin LeBlanc Site (Moncton)

 

Dr. Gilles Pinette Site (Winnipeg)